Device
Subcutaneous (SC) single dose
Subcutaneous (SC) single dose is a medical device with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_1
2
67%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 12 (66.7%)
N/A1 (33.3%)
Trials by Status
completed267%
active_not_recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
active_not_recruitingnot_applicable
Medicsen Smartpatch: Safety & Performance (SOUNDD)
NCT07615959
completedphase_1
A Phase I Clinical Study of ART101 Injection in Healthy Adult Subjects
NCT07529600
completedphase_1
A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers
NCT01563042
Clinical Trials (3)
Showing 3 of 3 trials
NCT07615959Not Applicable
Medicsen Smartpatch: Safety & Performance (SOUNDD)
NCT07529600Phase 1
A Phase I Clinical Study of ART101 Injection in Healthy Adult Subjects
NCT01563042Phase 1
A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3